Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV open multicenter study of Sheila Shenhuang ointment for superficial fungal disease
ChiCTR1800015095Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Hunan University of Chinese Medicine
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of shezhi shenhuang ointment, sponsored by The Second Affiliated Hospital of Hunan University of Chinese Medicine. Primary endpoints: Target skin lesion score, Itching efficacy and 1 more. Planned start Feb 2018; status: not yet recruiting.
02
Drugs
shezhi shenhuang ointment
Beyond the preview
Go deeper on ChiCTR1800015095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015095.